Israel moves to silence Al Jazeera, ban its journalists

Al Jazeera
August 7, 2017

Doha, Aug 7: Israel plans to revoke media credentials of Al Jazeera journalists and close the network's office in Jerusalem, the country's communication minister has announced.

Ayoub Kara made the announcement on Sunday during a press conference in Jerusalem, where Al Jazeera was barred from attending. 

"We have based our decision on the move by Sunni Arab states to close the Al Jazeera offices and prohibiting their work," Kara said, adding that the channel is being used by groups to "incite" violence - an accusation the network has denied.

Kara said he expects Israel's parliament, the Knesset, to consider his request in the next session.

"I will go through the [legislatorial] mechanism to create the authority in which I can act freely. We will try to end it as quickly as possible."

Al Jazeera denounces measures

In a statement, the Doha-based media network denounced the measures from a country it says claims to be "the only democracy in the Middle East".

"Al Jazeera stresses that it will closely watch the developments that may result from the Israeli decision, and will take the necessary legal measures towards it," the statement read.

Al Jazeera also denied the charges its coverage of al-Aqsa Mosque unrest was unprofessional. 

"Al Jazeera will continue to cover the events of the occupied Palestinian territories professionally and accurately, according to the standards set by international agencies, such as the UK Office of Communications (Ofcom)."

The pan-Arab network's offices in the Palestinian territories of Gaza and the occupied West Bank city of Ramallah would not be affected by the current Israeli move.

The Legal Center for Arab Minority Rights in Israel, also known as Adalah, challenged the plan, saying it would be subject to scrutiny before the Supreme Court, adding that "it would fail the test of legality".

Al Jazeera's Scott Heidler, reporting from Jerusalem on Sunday, said that the request to revoke the credentials cover all the network's journalists in both the Arabic and English channels. 

It was unclear when the government will act on the request.

Our correspondent reported that Israel is also seeking to shut down Al Jazeera's cable and satellite transmissions in the country.

During the press conference, Kara also said that the interior ministry will also be involved in shutting down Al Jazeera's office in Jerusalem.

Israeli Prime Minister Benjamin Netanyahu has repeatedly threatened to shut Al Jazeera's operations in the country, accusing the network of inciting violence against Israel. His most recent attack on July 27 accused the network of "inciting violence".

Marwan Bishara, Al Jazeera senior political analyst, said the latest move by Israel shows a "synergy" of "dictatorships" in the Arab world and "dictatorship of military occupation in Palestine".

"It is as if closing down a network will diminish violence, when everyone knows that repression and military occupation, and aggression is the reason for violence in the region. Not reporting it," he said.

Attack on press freedom

In an interview with Al Jazeera, Rami Khouri of the American University in Beirut, denounced the plan saying it is "very typical of regimes" in the region. 

"Regimes that want to control power will almost always go after two targets - the media and the foreigners. Everybody goes after the media." 

Aidan White, director of the London-based Ethical Journalism Network, called Israel's decision "a full frontal attack" on press freedom.

"It is a shocking statement, and it completely undermines Israel's claims to be the only democracy in the region, because it gets to the heart of one of the most important institutions of democracy.

"This attack on Al Jazeera is really an attack on all critical independent journalism."

The Committee to Protect Journalists has also criticised the Israeli move.

"Censoring Al Jazeera or closing its offices will not bring stability to the region, but it would put Israel firmly in the camp of some of the region's worst enemies of press freedom," CPJ Middle East and North Africa Programme Coordinator Sherif Mansour said in a statement.

"Israel should abandon these undemocratic plans and allow Al Jazeera and all journalists to report freely from the country and areas it occupies," it said.

In recent months, Saudi Arabia and Jordan both shut down Al Jazeera bureaus as part of a coordinated diplomatic and economic campaign against Qatar, where the headquarters of Al Jazeera Media Network is located.

Al Jazeera's signal has also been blocked in the United Arab Emirates. 

Egypt, which is also part of the blocking group, banned Al Jazeera several years ago. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 7,2020

Mar 7: Two Malayalam news channels, Asianet News and Media One, which were banned by the information and broadcasting ministry for their coverage of the recent violence in Delhi on Friday evening, were allowed to resume telecasting on Saturday morning.

While Asianet News appeared to have begun operations around 7am on Saturday, Media One was screening content by 9.30am.

The ministry of information and broadcasting had imposed a 48-hour ban on Asianet News and Media One for their coverage of the Delhi violence for 48 hours from 7.30pm on Friday. Both Asianet News and Media One were barred under Rule 6(1 c) and Rule 6(1e) of the Cable Television Networks Act, 1994.

The ministry of information and broadcasting alleged Asianet News and Media One were "biased" and critical of the RSS and Delhi Police.

The ban on Asianet News and Media One triggered a torrent of criticism of the move. Congress MP Shashi Tharoor asked how "Malayalam channels inflame communal passions in Delhi?" and alleged some English news channels were continuing "their brazen distortions" with impunity.

In a statement issued on Friday after the ban, Media One termed the move "unfortunate and condemnable" and called it a "blatant attack against free and fair reporting". Media One called it "an order to stop free and fair journalism".

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
April 27,2020

Riyad, Apr 27: The Saudi-led Arab Coalition supporting Yemen’s UN-recognized government on Monday urged all parties to end any escalation of hostilities and return to the status that existed before the Southern Transitional Council (STC) declared self-rule.

In a statement carried by the Saudi Press Agency (SPA), the coalition emphasized “the need to cancel any step that violates the Riyadh agreement and work to accelerate its implementation.” 

On Sunday, the United Arab Emirates-backed STC scrapped a peace deal with the internationally recognized government of President Abed Rabbo Mansour Hadi.

Accusing the government of corruption and mismanagement, the separatists said they would “self-govern” the key southern port city of Aden and other southern provinces.

Yemen’s Foreign Minister Mohammed Al-Hadhrami described the move as a “resumption of its (STC’s) armed insurgency and rejection and complete withdrawal from the Riyadh agreement.” 

Authorities in Yemen’s southern provinces of Hadramawt, Abyan, Shabwa, Al-Mahra and the remote island of Socotra also rejected the separatist group’s claim to self-rule.

The government said local and security authorities in the five provinces dismissed the move as a “clear and definite coup.” 

Some of the provinces issued their own statements condemning it.

The coalition appealed to all parties to “give priority to the interests of the Yemeni people over any other interests”. 

It also urged the parties involved not to lose their focus on working to achieve the goal of restoring the state, ending the Houthi “coup” and “countering terrorist organizations”.

“The Coalition has and will continue to undertake practical and systematic steps to implement the Riyadh Agreement between the parties to unite Yemeni ranks, restore state institutions and combat the scourge of terrorism,” the statement said. “The responsibility rests with the signatories to the Agreement to undertake national steps toward implementing its provisions, which were signed and agreed upon with a time matrix for implementation.”

The STC has been part of the coalition-backed forces fighting the Iran-backed Houthi militia, which seized control of the Yemeni capital Sanaa and other provinces in 2014.

The Houthi “coup” has led to the formation of the Saudi-led coalition, which had since driven away the Houthis from the south and other provinces. President Hadi’s government has made Aden as its temporary seat.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.